We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ZyGEM Acquires Microlab Diagnostics to Commercialize Breakthrough DNA Detection and Testing Platform
News

ZyGEM Acquires Microlab Diagnostics to Commercialize Breakthrough DNA Detection and Testing Platform

ZyGEM Acquires Microlab Diagnostics to Commercialize Breakthrough DNA Detection and Testing Platform
News

ZyGEM Acquires Microlab Diagnostics to Commercialize Breakthrough DNA Detection and Testing Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ZyGEM Acquires Microlab Diagnostics to Commercialize Breakthrough DNA Detection and Testing Platform"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ZyGEM intends to market products integrating its DNA extraction, reagent and detection assays with the breakthrough microfluidic chip technology developed by MicroLab, which will operate as a business unit of the new company. These integrated new products will dramatically decrease the time, complexity and cost of conducting DNA testing and have transformational potential in a broad range of applications. 
 
Data presented at a recent scientific meeting demonstrated that a prototype of the new system produced accurate DNA results in less than an hour, comparable to results obtained with current technology requiring three separate instruments and five to 10 hours.  The new technology has the potential to revolutionize DNA testing for the many applications where accuracy, speed and ease-of-use are critical, including, forensics, biodefense, point-of-care diagnostics and food pathogen testing.
.
“Combining ZyGEM’s unique assays and reagents with MicroLab’s revolutionary microfluidic chips will enable us to greatly expand the utility of DNA detection for both existing and new applications,” said Paul Kinnon, chief executive officer of ZyGEM.  “Even better, the transformative power of our technology is not a future dream—we have already presented data confirming our ability to achieve accurate results with unprecedented speed and ease-of-use.  We intend to rapidly develop and commercialize our new platform with the help of selected partners.”
 
MicroLab Diagnostics has developed advanced microfluidics chip technology that is exclusively licensed to the new company.  MicroLab’s miniaturization of the entire DNA testing process within a single closed system has many advantages.  It significantly reduces the amount of sample and reagents that are needed while virtually eliminating the chances for handling error or contamination.  The ZyGEM/MicroLab system is compact, easy-to-use and cost-effective, making it suitable for use both in the laboratory and out in the field.  It can perform multiplexed analyses and can also be configured for specific applications.  Portable handheld versions are in development.
Advertisement